Peter Evan Harwin, Director at Zenas BioPharma, Inc. (ZBIO), bought 601,077 shares at $17.00 ($5.1M) on 2024-09-16, disclosed to the SEC on 2024-09-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 301,077 | $0 | 0.0% |
| 2 | $17.00 | 300,000 | $5.1M | 100.0% |
| Total | $8.48 avg | 601,077 | $5.1M | 100% |
| Filing → |
| ZBIO | BUY | 2025-10-09 | $6.0M | — | Filing → |
| DNTH | BUY | 2023-10-03 | $673K | — | Filing → |